@article{AES4418,
author = {Doran B. Spencer and Nicholas J. Protopsaltis and Daniel L. Chao},
title = {New pharmacotherapies for diabetic retinopathy},
journal = {Annals of Eye Science},
volume = {3},
number = {8},
year = {2018},
keywords = {},
abstract = {Diabetic retinopathy (DR) is the most common microvascular complication in patients with diabetes mellitus (DM), and remains the single greatest cause of blindness in working age adults around the world. In this article, we review the evolution of pharmacotherapies for both diabetic macular edema (DME) and DR such as anti-vascular endothelial growth factor inhibitors and various steroid formulations, as well as other emerging pharmacotherapies currently in late stage clinical testing for this disease.},
issn = {2520-4122}, url = {https://aes.amegroups.org/article/view/4418}
}